UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Northcape Wealth Management LLC

Northcape Wealth Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,308 shares of the healthcare conglomerate’s stock after purchasing an additional 31 shares during the quarter. Northcape Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,519,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates increased its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $32,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Bank of America cut their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $615.53.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Down 0.2 %

UNH stock opened at $592.18 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a fifty day moving average price of $582.84 and a two-hundred day moving average price of $549.06. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $544.97 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company earned $6.56 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.